American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.

GLP-1 drugs have also demonstrated potential in reducing risks of several substance use disorders such as those involving alcohol, tobacco, cannabis, opioids and stimulants. This may be due to the ...

( MENAFN - Swissinfo) Swiss medicines regulator Swissmedic has taken legal action against media houses in Switzerland for ...

Millions of obese Americans have achieved successful weight loss through use of glucagon-like peptide-1 agonists (GLP-1), a game-changing class of obesity medications. Results are often dramatic, but ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer and dementia, a sweeping n ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

This figure is $400 million below the low end of the company’s prior guidance and includes $3.5 billion from its type 2 ...

Times-Review, a CNHI newspaper. It does not necessarily reflect the opinion of The Tribune- Democrat. Forty percent of Americans are said to be obese. This has been going on for some time. Cheap ...

TOKYO (AP) — Asian shares traded mixed Tuesday, echoing Wall Street trading, where gains for oil-and-gas producers helped ...

Stocks gained ground on Wall Street following an encouraging update on inflation. The S&P 500 rose 0.3% in afternoon trading ...

Actually, the best way to lose weight, doctors agree, is through healthy diet and physical activity. People always crave the fastest and easiest, but fast and easy are not always equal to best.